Search research articles
Contact Us
Filters
Showing results (271-280 of 316) with videos related to
Page
of 32
Sort By:
Acta Neuropsychiatrica
|
June 7, 2019
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials
Ole Köhler-Forsberg, Louisa G Sylvia, Charles L Bowden, et al.
Bipolar Disorders
|
May 8, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, et al.
Psychiatry Research
|
September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response
Ole Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.
Depression and Anxiety
|
June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials
Ole Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.
Bipolar Disorders
|
July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
Mauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Journal of Affective Disorders
|
July 30, 2017
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder
Ole Köhler-Forsberg, Trine Madsen, Ida Behrendt-Møller, et al.
Journal of Affective Disorders
|
December 24, 2021
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response
Maya Kuperberg, Ole Köhler-Forsberg, Alec P Shannon, et al.
Journal of Affective Disorders
|
April 16, 2017
Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study
Mauricio Tohen, Alexandra K Gold, Louisa G Sylvia, et al.
Research Square
|
May 15, 2024
Differential contributions of circadian clock genes to cell survival in bipolar disorder patient derived neuronal progenitor cells distinguishes lithium responders and non-responders
Himanshu K Mishra, Heather Wei, Melissa LeRoux, et al.
Nature Medicine
|
April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Andrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 316) with videos related to
Sort By:
Page
of 32
Acta Neuropsychiatrica
|
June 7, 2019
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials
Ole Köhler-Forsberg, Louisa G Sylvia, Charles L Bowden, et al.
Bipolar Disorders
|
May 8, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, et al.
Psychiatry Research
|
September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response
Ole Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.
Depression and Anxiety
|
June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials
Ole Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.
Bipolar Disorders
|
July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
Mauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Journal of Affective Disorders
|
July 30, 2017
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder
Ole Köhler-Forsberg, Trine Madsen, Ida Behrendt-Møller, et al.
Journal of Affective Disorders
|
December 24, 2021
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response
Maya Kuperberg, Ole Köhler-Forsberg, Alec P Shannon, et al.
Journal of Affective Disorders
|
April 16, 2017
Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study
Mauricio Tohen, Alexandra K Gold, Louisa G Sylvia, et al.
Research Square
|
May 15, 2024
Differential contributions of circadian clock genes to cell survival in bipolar disorder patient derived neuronal progenitor cells distinguishes lithium responders and non-responders
Himanshu K Mishra, Heather Wei, Melissa LeRoux, et al.
Nature Medicine
|
April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Andrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Page
of 32